168 related articles for article (PubMed ID: 38582810)
1. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.
Wang Z; Tang S; Cai L; Wang Q; Pan D; Dong Y; Zhou H; Li J; Ji N; Zeng X; Zhou Y; Shen YQ; Chen Q
Br J Cancer; 2024 May; 130(11):1744-1757. PubMed ID: 38582810
[TBL] [Abstract][Full Text] [Related]
2. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
3. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
Luo Y; Li W; Ling Z; Hu Q; Fan Z; Cheng B; Tao X
Cancer Med; 2020 May; 9(10):3489-3499. PubMed ID: 32162845
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells.
Zhang Y; Yang B; Tu C; Ping Y; Chen S; Wu T; Zhao Z; Mao Y; Yang Z; Cao Z; Li J; Huang K; Ding X; Wu G; Zou P; Deng Z; Sun X
J Transl Med; 2023 May; 21(1):328. PubMed ID: 37198593
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer.
Dai W; Wang G; Chwa J; Oh ME; Abeywardana T; Yang Y; Wang QA; Jiang L
Br J Cancer; 2020 Apr; 122(9):1288-1297. PubMed ID: 32147668
[TBL] [Abstract][Full Text] [Related]
6. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
[TBL] [Abstract][Full Text] [Related]
7. Quercetin induces ferroptosis by inactivating mTOR/S6KP70 pathway in oral squamous cell carcinoma.
Zhu YW; Liu CL; Li XM; Shang Y
Toxicol Mech Methods; 2024 Jul; 34(6):669-675. PubMed ID: 38736312
[TBL] [Abstract][Full Text] [Related]
8. Glutamine deficiency promotes stemness and chemoresistance in tumor cells through DRP1-induced mitochondrial fragmentation.
Prasad P; Ghosh S; Roy SS
Cell Mol Life Sci; 2021 May; 78(10):4821-4845. PubMed ID: 33895866
[TBL] [Abstract][Full Text] [Related]
9. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.
Luo M; Wu L; Zhang K; Wang H; Zhang T; Gutierrez L; O'Connell D; Zhang P; Li Y; Gao T; Ren W; Yang Y
Cell Death Differ; 2018 Aug; 25(8):1457-1472. PubMed ID: 29348676
[TBL] [Abstract][Full Text] [Related]
10. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.
Cetindis M; Biegner T; Munz A; Teriete P; Reinert S; Grimm M
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):495-503. PubMed ID: 25663193
[TBL] [Abstract][Full Text] [Related]
11. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.
Song A; Wu L; Zhang BX; Yang QC; Liu YT; Li H; Mao L; Xiong D; Yu HJ; Sun ZJ
Cancer Lett; 2024 Apr; 588():216727. PubMed ID: 38431035
[TBL] [Abstract][Full Text] [Related]
12. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
13. Clinico-pathological significance of Drp1 dysregulation and its correlation to apoptosis in oral cancer patients.
Ghosh A; Chatterjee K; Chowdhury AR; Barui A
Mitochondrion; 2020 May; 52():115-124. PubMed ID: 32169612
[TBL] [Abstract][Full Text] [Related]
14. Drp1 regulates mitochondrial morphology and cell proliferation in cutaneous squamous cell carcinoma.
Kitamura S; Yanagi T; Imafuku K; Hata H; Abe R; Shimizu H
J Dermatol Sci; 2017 Dec; 88(3):298-307. PubMed ID: 28818497
[TBL] [Abstract][Full Text] [Related]
15. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
[TBL] [Abstract][Full Text] [Related]
16. Dynamin-related protein 1 inhibition reduces hepatic PCSK9 secretion.
Rogers MA; Hutcheson JD; Okui T; Goettsch C; Singh SA; Halu A; Schlotter F; Higashi H; Wang L; Whelan MC; Mlynarchik AK; Daugherty A; Nomura M; Aikawa M; Aikawa E
Cardiovasc Res; 2021 Sep; 117(11):2340-2353. PubMed ID: 33523181
[TBL] [Abstract][Full Text] [Related]
17. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
[TBL] [Abstract][Full Text] [Related]
18. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
19. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
20. PPARĪ³ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis.
Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J
Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
